2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Monday, September 23, 2019

1:45pm-3:15pm: BeaT-PD, An Industry-Academic Collaboration to Understand PD Progression in Ashkenazi Jews

N. Giladi, A. Orr-Urtreger, M. Gana-Weisz, A. Thaler, O. Goldstein, M. Lalioti, K. Evans, M. Hutchison, O. Mabrouk, A. Dowling, T. Fox, M. Yang, K. Parekh, E. Even Sapir, D. Ben Baast, M. Artzi, H. Lerman, L. Yachimovich, B. Cohen, S. John, A. Mirelman, J. Cederbaum (Tel Aviv, Israel)

Genetics · Les Muses Terrace, Level 3

1:45pm-3:15pm: Behavioural aspect of transgenic Drosophila melanogaster as a model of Parkinson’s disease treated by Ropinirole alginate nanocomposite

F. Naz, R. X, YHS. Siddique (Aligarh, India)

Neuropharmacology · Les Muses Terrace, Level 3

1:45pm-3:15pm: Beliefs, Knowledge and Attitudes Towards Parkinson’s Disease: Turkey Experience from a Global Perspective

Y. Degirmenci, P. Limousin, GM. Hariz, N. Cakar (Duzce, Turkey)

Quality of Life · Les Muses Terrace, Level 3

1:45pm-3:15pm: Benefit and Weakness with botulinum toxin: time course and relationship.

P. Kassavetis, K. Alter, C. Lungu, B. Karp (Bathesda, MD, USA)

Neuropharmacology · Les Muses Terrace, Level 3

1:45pm-3:15pm: Benign hereditary chorea: A Tunisian family case presentation

M. Akkari, H. Ben Rhouma, H. Klaa, A. Rouissi, I. Kraoua, I. Turki (Tunis, Tunisia)

Choreas (Non-Huntington’s Disease) · Les Muses, Level 3

1:45pm-3:15pm: Bilateral Putaminal AAV2-GDNF Delivery the Treatment of Advanced Parkinson’s Disease

K. Bankiewicz, C. Lungu, D. Hammoud, P. Herscovitch, D. Ehrlich, D. Argersinger, S. Sinharay, G. Scott, T. Wu, W. San Sebastian, V. Suhakar, M. Fiandaca, K. Zaghloul, M. Hallett, R. Lonser, J. Heiss (San Francisco, CA, USA)

Gene and Cell-Based Therapies · Les Muses Terrace, Level 3

1:45pm-3:15pm: Biomarkers of idiopathic REM sleep behavior disorder versus RBD within narcolepsy

E. Antelmi, F. Pizza, Y. Sosero, V. Donadio, A. Incensi, R. Liguori, G. Plazzi (Bologna, Italy)

Restless Leg Syndrome, RBD and Other Sleep Disorders · Les Muses Terrace, Level 3

1:45pm-3:15pm: Biphasic Dyskinesias in Parkinson’s disease Patients treated with Levodopa/Carbidopa Intestinal Gel: Insights from a Multicenter Retrospective Analysis

M. Marano, T. Naranian, L. Di Biase, A. Di Santo, R. Arca, G. Cossu, P. Marano, V. Di Lazzaro, A. Fasano (Rome, Italy)

Clinical Trials, Pharmacology and Treatment · Agora 3 West, Level 3

1:45pm-3:15pm: Botulinum Neurotoxin (BoNT) treatment in functional movement disorders: an extended follow up

J. Dijk, M. Tijssen, J. Koelman, Y. Dreissen, F. Lambert (Groningen, Netherlands)

Functional (Psychogenic) Movement Disorders · Les Muses Terrace, Level 3

1:45pm-3:15pm: Botulinum toxin treatment of muscle spasms in a case of Satoyoshi syndrome

I. Bledsoe (San Francisco, CA, USA)

Other · Agora 2 West, Level 2